Author: Oncotarget

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form.
Oncotarget

Open-Access Oncotarget Shifts to Continuous Publishing

January 6, 2022
As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous publishing. — Listen to an audio version of this announcement BUFFALO, NY, January 6, 2022 – Since its inception in… read more
Dr. Jennifer Sheng
Oncotarget

Testimonial: Dr. Jennifer Sheng

December 10, 2021
Dr. Jennifer Sheng from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center shares her experience publishing "Innovating and expanding weight loss strategies for breast cancer survivors" with Oncotarget. Listen to an audio… read more
Dr. Gina Abdelaal
Oncotarget

Testimonial: Dr. Gina Abdelaal

December 3, 2021
Dr. Gina Abdelaal from Northumbria University discusses her experience publishing “Reversing oncogenic transformation with iron chelation,” with Oncotarget. Listen to an audio version of this post Dr. Gina Abdelaal I selected Oncotarget because… read more
Dr. Monica Varun Tyagi
Oncotarget

Testimonial: Dr. Monica Varun Tyagi

November 25, 2021
Dr. Monica Varun Tyagi discusses her experience publishing “GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3,” with Oncotarget. Listen to an audio… read more
Dr. Michael Roehrl
Oncotarget

Testimonial: Dr. Michael Roehrl

November 19, 2021
Dr. Michael Roehrl from the Department of Pathology, Memorial Sloan Kettering Cancer Center discusses his experience while publishing the paper, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal… read more